2022
DOI: 10.1016/j.jconrel.2022.03.059
|View full text |Cite
|
Sign up to set email alerts
|

Heterojunction engineered bioactive chlorella for cascade promoted cancer therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
48
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(55 citation statements)
references
References 63 publications
1
48
0
Order By: Relevance
“…This may be due to the generation of tumor antigens after NIR laser irradiation, which enhances the immune response. [ 20 ] These results confirm that AP FeNSs can enhance the population of M1 TAMs in the tumor, which potentially can activate prodrug AQ4N into AQ4 for synergistic immunotherapy and chemotherapy.…”
Section: Resultssupporting
confidence: 53%
“…This may be due to the generation of tumor antigens after NIR laser irradiation, which enhances the immune response. [ 20 ] These results confirm that AP FeNSs can enhance the population of M1 TAMs in the tumor, which potentially can activate prodrug AQ4N into AQ4 for synergistic immunotherapy and chemotherapy.…”
Section: Resultssupporting
confidence: 53%
“…PDT and SDT are both treatments transforming the molecular oxygen into cytotoxic 1 O 2 in tumor area towards the ablation of tumor cells, in which the photosensitizers or sonosensitizers react with the endogenous O 2 in the presence of appropriate light illumination or ultrasound treatment, respectively [ 2 , 143 ]. However, limited to the hypoxia condition in the tumor area, PDT or SDT could be combined with other treatment strategies for superior anticancer efficacy than a single treatment [ 144 ]. A synergistic strategy of combining PTT and SDT was proposed by integrating iridium complexes into black-titanium nanoparticles camouflaged with cancer cell membranes.…”
Section: Applications In Cancer Nano-immunotherapymentioning
confidence: 99%
“…However, a single therapy modality often suffers from limited therapeutic efficacy. Recent advances in cancer therapy have gradually shifted from a focus on single therapy to synergistic therapy [ [75] , [76] , [77] ]. Based on the synergistic enhancement interactions between two or more therapy, which may result in ostentatious superadditive (namely “1 ​+ ​1>2”) therapeutic effects [ 78 ].…”
Section: Bifunctional Scaffold For Tumor Therapy and Bone Regenerationmentioning
confidence: 99%